These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 37236726)

  • 1. Equine Endocrine Disease: Challenges With Case Definition for Research.
    McGowan CM; Ireland JL
    J Equine Vet Sci; 2023 May; 124():104491. PubMed ID: 37236726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocrine Disease in Aged Horses.
    Durham AE
    Vet Clin North Am Equine Pract; 2016 Aug; 32(2):301-15. PubMed ID: 27449391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic Testing for Equine Endocrine Diseases: Confirmation Versus Confusion.
    McFarlane D
    Vet Clin North Am Equine Pract; 2019 Aug; 35(2):327-338. PubMed ID: 31076223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of equine endocrinopathies: The value of measuring blood glucose during an oral glucose test.
    de Laat MA; Sillence MN
    Vet J; 2023; 300-302():106034. PubMed ID: 37778651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Equine pituitary pars intermedia dysfunction.
    McFarlane D
    Vet Clin North Am Equine Pract; 2011 Apr; 27(1):93-113. PubMed ID: 21392656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endocrine Disorders of the Equine Athlete.
    Frank N
    Vet Clin North Am Equine Pract; 2018 Aug; 34(2):299-312. PubMed ID: 29857965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Science-in-brief: Workshop report The Dorothy Havemeyer International Equine Endocrinology Summit.
    Durham AE; Bailey SR; Frank N; McFarlane D; Schott HC; Paradis MR
    Equine Vet J; 2017 Jul; 49(4):408-409. PubMed ID: 28603950
    [No Abstract]   [Full Text] [Related]  

  • 8. Equine pituitary pars intermedia dysfunction: current understanding and recommendations from the Australian and New Zealand Equine Endocrine Group.
    Secombe CJ; Bailey SR; de Laat MA; Hughes KJ; Stewart AJ; Sonis JM; Tan R
    Aust Vet J; 2018 Jul; 96(7):233-242. PubMed ID: 29862508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of combined testing to simultaneously diagnose pituitary pars intermedia dysfunction and insulin dysregulation in horses.
    Horn R; Bertin FR
    J Vet Intern Med; 2019 Sep; 33(5):2249-2256. PubMed ID: 31498947
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with survival, laminitis and insulin dysregulation in horses diagnosed with equine pituitary pars intermedia dysfunction.
    Horn R; Bamford NJ; Afonso T; Sutherland M; Buckerfield J; Tan RHH; Secombe CJ; Stewart AJ; Bertin FR
    Equine Vet J; 2019 Jul; 51(4):440-445. PubMed ID: 30417404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of Age, Season, Body Condition, and Endocrine Status on Serum Free Cortisol Fraction and Insulin Concentration in Horses.
    Hart KA; Wochele DM; Norton NA; McFarlane D; Wooldridge AA; Frank N
    J Vet Intern Med; 2016; 30(2):653-63. PubMed ID: 26860336
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of Common Equine Endocrine Diseases on Reproduction.
    Burns TA
    Vet Clin North Am Equine Pract; 2016 Dec; 32(3):435-449. PubMed ID: 27726988
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of principle component analysis to quantitatively score the equine metabolic syndrome phenotype in an Arabian horse population.
    Lewis SL; Holl HM; Long MT; Mallicote MF; Brooks SA
    PLoS One; 2018; 13(7):e0200583. PubMed ID: 30001422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circannual variation in plasma adrenocorticotropic hormone concentrations in the UK in normal horses and ponies, and those with pituitary pars intermedia dysfunction.
    Copas VE; Durham AE
    Equine Vet J; 2012 Jul; 44(4):440-3. PubMed ID: 21848531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetics of Equine Endocrine and Metabolic Disease.
    Norton E; McCue ME
    Vet Clin North Am Equine Pract; 2020 Aug; 36(2):341-352. PubMed ID: 32534851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutics for Equine Endocrine Disorders.
    Durham AE
    Vet Clin North Am Equine Pract; 2017 Apr; 33(1):127-139. PubMed ID: 28190613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adrenocorticotropin concentration following administration of thyrotropin-releasing hormone in healthy horses and those with pituitary pars intermedia dysfunction and pituitary gland hyperplasia.
    Beech J; Boston R; Lindborg S; Russell GE
    J Am Vet Med Assoc; 2007 Aug; 231(3):417-26. PubMed ID: 17669045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of adrenocorticotrophic hormone as a potential biomarker of pituitary pars intermedia dysfunction in horses.
    Lee ZY; Zylstra R; Haritou SJ
    Vet J; 2010 Jul; 185(1):58-61. PubMed ID: 20537574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of single and paired measurements of adrenocorticotropic hormone for the diagnosis of pituitary pars intermedia dysfunction in horses.
    Rendle DI; Duz M; Beech J; Parkin T; Durham AE
    J Vet Intern Med; 2015 Jan; 29(1):355-61. PubMed ID: 25312676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of freeze-thaw cycles on determination of immunoreactive plasma adrenocorticotrophic hormone concentrations in horses.
    Hu K; Stewart AJ; Yuen KY; Hinrichsen S; Dryburgh EL; Bertin FR
    J Vet Intern Med; 2020 May; 34(3):1350-1356. PubMed ID: 32255541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.